title: Corrigendum: IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel.
authors.forename: Zhen Ning
authors.initials: ZN
authors.lastname: Wee
authors.forename: Siti Maryam J M
authors.initials: SMJM
authors.lastname: Yatim
authors.forename: Vera K
authors.initials: VK
authors.lastname: Kohlabauer
authors.forename: Min
authors.initials: M
authors.lastname: Feng
authors.forename: Jian Yuan
authors.initials: JY
authors.lastname: Goh
authors.forename: Yi
authors.initials: Y
authors.lastname: Bao
authors.forename: Puay Leng
authors.initials: PL
authors.lastname: Lee
authors.forename: Songjing
authors.initials: S
authors.lastname: Zhang
authors.forename: Pan Pan
authors.initials: PP
authors.lastname: Wang
authors.forename: Elgene
authors.initials: E
authors.lastname: Lim
authors.forename: Wai Leong
authors.initials: WL
authors.lastname: Tam
authors.forename: Yu
authors.initials: Y
authors.lastname: Cai
authors.forename: Henrik J
authors.initials: HJ
authors.lastname: Ditzel
authors.forename: Dave S B
authors.initials: DSB
authors.lastname: Hoon
authors.forename: Ern Yu
authors.initials: EY
authors.lastname: Tan
authors.forename: Qiang
authors.initials: Q
authors.lastname: Yu